Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Personalized Medicine Market: An Introduction

4. Personalized Medicine Market
     4.1 Therapeutics
            4.1.1 Cancer
            4.1.2 Cardiovascular Diseases
            4.1.3 Neurological Disorders
     4.2 Diagnostics

5. Market Participants
     5.1 Pharmaceutical Companies
     5.2 Diagnostic Companies
     5.3 Technology Providers
     5.4 Healthcare Providers
     5.5 Insurance Companies

6. Key Geographical Markets
     6.1 US
     6.2 Europe
     6.3 Emerging Markets
            6.3.1 Japan
            6.3.2 China
            6.3.3 India

7. Market Drivers and Restraints
     7.1 Drivers
            7.1.1 Increasing Focus of Personalized Medicine in Cancer
            7.1.2 Robust Advancements in Pharmacogenomics and Pharmacogenetics
            7.1.3 Personalization for Prevention of ADR’s
            7.1.4 Healthcare Costs Savings
     7.2 Restraints
            7.2.1 Reimbursement
            7.2.2 Privacy, Confidentiality and Patients' Rights

8. Regulatory Environment

9. Competitive Landscape
     9.1 Pharma/Biotech Companies
            9.1.1 Abbott Laboratories
            9.1.2 Genzyme Corporation
            9.1.3 Novartis AG
            9.1.4 Bristol-Myers Squibb Company
     9.2 IT/Informatics Companies
            9.2.1 IBM
            9.2.2 Oracle Health Sciences
            9.2.3 XIFIN, Inc.
            9.2.4 CTIS, Inc.
     9.3 Diagnostic Companies
            9.3.1 Siemens
            9.3.2 Roche
            9.3.3 Rosetta Genomics Ltd.
            9.3.4 QIAGEN N.V.
            9.3.5 Gen-Probe Incorporated
            9.3.6 Dako Denmark A/S
            9.3.7 BioMérieux SA
     9.4 Research Tool Companies
            9.4.1 Affymetrix, Inc.
            9.4.2 DNA Genotek
            9.4.3 Illumina, Inc.
            9.4.4 Life Technologies Corporation
            9.4.5 Pacific Biosciences